Author: Sutun Nayak

Noida (Uttar Pradesh) [India], November 4: Phoenix Plants Lifesaver Pvt Ltd, which has been a giant in the Indian fertiliser sector infrastructure landscape, stated that it experienced great milestones in its functioning, network, and its dedication to sustainable agriculture. The company was founded in 2021 with the intention of transforming the farm sector by addressing the issues that farmers had.

Farmer Reach and Expansive Network.
Phoenix Plants Lifesaver has established a good network within the country. It serves 8 states and 189 cities with over 5,500 retail service centers as well as Farmer Service Cooperative Societies that deliver the products directly to farmers.

Important Statistic: Phoenix Plants Lifesaver has over 1.5 million farmers with whom they are now linked.
The firm will target all rural farmers in India by 2025 and venture into the foreign market.

State of the Art Production and Quality Control.
Phoenix Plants Lifesaver operates one of the largest plants in North India to facilitate growth. The completely mechanised plant manufactures 50,000 litres of liquid fertiliser and 600 metric tons of solid fertiliser per day, whereby quality checks are very stringent in order to come out with high-quality inputs.

Target Research and Sustainable Solutions.
Phoenix Plants Lifesaver enhances its research and development unit by advancing its labs with the aim of supporting its commitment to offering innovative and sustainable services to farmers.

NPK 22:22:11 Fertiliser Gains Traction.
NPK 22:22:11 is a type of balanced fertiliser popular in Uttar Pradesh, Haryana, and other states, which is produced by Phoenix. It enhances the production of crops and has nitrogen, which promotes the growth of crops, phosphorus, which ensures the pruning of roots and fruits, and potash, which ensures resistance against diseases and the quality of grains.

Individual farmers like Ram Pal Singh and Sunita Devi have been reporting as much as a 20 per cent increase in the yield. Insiders at Krishi Vigyan Kendra assert that the use of balanced fertilisers contributes to maintaining the fertility of the soils as well as raising the incomes of the farmers.

Phoenix Plants Lifesaver is determined towards growth, purity and progress of Indian farmers and works towards being a new source of hope in the agricultural industry.

Mumbai (Maharashtra) [India], November 4: Cupid Limited, (BSE – 530843, NSE – CUPID), Cupid Limited, a global provider of wellness and public-health products, announced that it has secured a leading position in South Africa’s five-year (2025–2030) national procurement program for Female Condoms (FC) and Male Condoms (MC). Based on allocation notifications shared with approved distributors, procurement is expected to commence from December 2025.

Allocation snapshot (annual/yearly)

• Female Condoms (FC): 23.4 million units allocated to Cupid across approved SA distributors, 59% share of the 40 million units/year allocated among all suppliers.
• Male Condoms (MC): 0.77 million boxes/year (200 pcs/box) across variants, equal to 153 million pieces/year.

Financial visibility for Cupid Limited (annual/indicative)

• Female Condoms: USD 8.89 million (Rs. 79 Crores Approx.)
• Male Condoms: USD 4.09 million (Rs. 36 Crores Approx.)
• Total: USD 12.98 million (Rs. 115 Crores Approx.)

Execution readiness

Cupid is in pole position to supply against these allocations and is:

• Coordinating closely with South African approved distributors for phased call-offs and distribution starting December 2025.
• Finalizing local labeling/artwork and pack variants (FC flavors: Strawberry / Vanilla / Caramel; MC flavors: Vanilla / Banana / Grape / Strawberry) as per tender specifications.
• Scheduling capacity blocks, QA lots, and logistics to support uninterrupted deliveries throughout FY26 and beyond.

Commenting on the Development, Mr. Aditya Kumar Halwasiya, Chairman and Managing Director said, “These allocations place Cupid at the forefront of South Africa’s prevention program. We’re working on the ground with our customers and the public-health system to ensure a smooth start in December 2025 and consistent supplies thereafter. This is the highest ever multi-year visibility milestone and a validation of our quality and reliability.

This outcome will notably strengthen our international order pipeline and will allow us to exceed our annual guidance given previously. This further reinforces our conviction for the capacity expansion underway at Cupid.

I must thank the South African Authorities for reposing their faith in Cupid and we will work diligently to reaffirm their faith in us.”

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

New Delhi [India], November 4: For over three decades, Mr. Prakash Gaur has been at the forefront of India’s infrastructure transformation. An Economist and Planner by training, Mr. Gaur played a pivotal role in the creation of GIFT City, India’s first International Financial and Smart City, and later served as Director (Strategy) for the Government of Andhra Pradesh, where he helped shape the new capital, Amaravati. From 2021 to 2025, as the founding CEO and Director of National Highways Logistics Management Ltd (NHLML) under the Ministry of Road Transport and Highways, he spearheaded the development of 35 Multimodal Logistics Parks (MMLPs), 15 ropeway projects, and 750 highway amenities under PPP models, while revitalizing several port connectivity ventures. Our cities evolve faster than the systems that support them, and our ambitions often reach farther than our access.

Along the way, many journeys pause before they fulfil their purpose. We have built roads, yet the true connection between people is still taking shape. What we lose is not just speed, but moments of time that could create, and transform. That loss of time isn’t just inconvenience; it’s the cost of opportunity. That’s the gap Mr. Prakash Gaur has spent his career closing. And now, that mission finds a larger canvas at aerpace. Now, at aerpace, he joins not just to lead, but to help build what comes next. With Mr. Gaur’s leadership, aerpace will accelerate the expansion of the aerVerse, unifying aerVolt, aerDock, aerWing, and aerCar into a seamless framework that delivers zero emission mobility across the nation. From powering rural access to enabling faster logistics, from connecting cities through ecosystems that respond to human need. “My vision is simple,” said Mr. Prakash Gaur, Director, aerpace Industries Ltd. “A farmer in Nanded should be able to send his fresh produce to Mumbai within minutes.

A person facing a medical emergency in a small village in Haryana should reach a quality hospital in Delhi without delay, because life cannot be compromised. Today, a traveller can fly from Mumbai to Bengaluru in two hours, yet spend more time reaching the city from its own airport. “Our challenge has never been ambition; it has been access,” he added. “With aerpace, we have the opportunity to build an ecosystem where every citizen, from remote villages to global cities — can move freely and intelligently. We’re not just building systems; we’re creating access, purpose, and time.” “Mr. Gaur’s experience strengthens our vision to build an India that moves seamlessly,” added Ravi Soni, Executive Director, aerpace Industries Ltd. “Together, we are designing an ecosystem where progress is sustainable, inclusive, and deeply human, where every innovation helps people MakeTime for what truly matters.” About aerpace aerpace Industries Ltd. is a deep-tech company building a unified ecosystem of sustainable energy, autonomous mobility, intelligent infrastructure, and national defence.

Through its verticals — aerVolt, aerDock, aerWing, aerCar, aerShield, and aerOS — aerpace is creating the aerVerse, a seamless network that redefines how the world moves. Guided by its purpose to MakeTime, aerpace is designing a future where opportunity, access, and progress belong to everyone.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Mumbai (Maharashtra) [India], November 4: Fischer Medical Ventures Limited (FISCHER | 524743 | INE771F01041), Time Medical International Ventures (I) P LTD, the wholly owned subsidiary of Fischer Medical Ventures Limited, today announced a strategic collaboration with globally acclaimed neurosurgeon, educator, and innovator Dr Iype Cherian. The collaboration’s sole purpose is the development of DRIS–iMRI Medharanya, a revolutionary new variant of advanced MRI technology.

Time Medical International Ventures (I) P LTD, a global leader in advanced medical imaging solutions and a wholly owned subsidiary of Fischer Medical Ventures Ltd (FMVL), has announced a significant collaboration with renowned medical expert, Dr Cherian.

Headquartered in Chennai, Time Medical India, specialising in the design and manufacture of cost-effective, high-performance MRI systems, aims to democratize access to advanced diagnostic imaging globally. Through this partnership, they will jointly develop DRIS–iMRI Medharanya, a revolutionary, next-generation, AI-enabled portable and specialised MRI system.

This groundbreaking technology integrates Augmented Reality (AR), Artificial Intelligence (AI), Machine Learning (ML), and Exoscope technologies. Designed to be an Interop MRI, the system will revolutionise complex neurosurgical procedures by providing surgeons with real-time visualisation, enabling unprecedented precision and safety.

Clinically, DRIS–iMRI Medharanya will also integrate the Extradural Parasigmoid approach to the Jugular Foramen (Ex Pa JuF), a cutting-edge surgical pathway for managing complex glomus tumours with enhanced safety and anatomical clarity. This innovation is a pivotal step toward democratising advanced diagnostics, bringing high-performance, cost-effective imaging to every corner of the globe.

About Dr. Iype Cherian

Dr. Iype Cherian is a pioneering neurosurgeon, educator, and innovator whose distinguished career embodies surgical mastery, inventive spirit, and global impact. After completing his M.Ch (Neurosurgery) at CMC Vellore and a Fellowship in Skull Base and Vascular Neurosurgery at Nagoya, he has devoted his life to advancing neurosurgical science and education. His groundbreaking contributions include the description of Craniotomy (2007) and the concept of Brain Cooling, both of which have influenced contemporary neurosurgical practice and postoperative recovery strategies.

Renowned for “Unlocking the Skull Base,” he has developed advanced microsurgical routes such as the Transcavernous and Modified Kawase approaches, creating safer access

to complex intracranial regions. His inventive portfolio — including the Sanma Yoko Exoscope, STMC Bypass Set, Medharanya Theatre Concept, Sookshmaranga Endovascular Robot, and now DRIS– iMRI Medharanya — reflects his mission to democratize precision surgery.

Currently serving as Director of Neuro Sciences at the Nepal Institute of Medical Sciences & Research and as faculty at the Institute of NeuroSciences, Krishna Institute of Medical Sciences, Karad, he continues to mentor surgeons worldwide through Neurosurgery Coach, his global training initiative promoting advanced micro-neurosurgical skill development.

Under this collaboration, Dr Iype Cherian will assume the role of Director – Neurosciences at Time Medical India, where he will guide the clinical innovation, neuroimaging design, and translational strategy of the DRIS–iMRI Medharanya program. This partnership reflects Time Medical’s commitment to advancing imaging technology that bridges intelligence, accessibility, and human-centred design.

Dr. Iype Cherian, Neurosurgeon at Parul University, explained: “Glioma surgery is generally a blind surgery. Interoperative MRI gives vision to the surgeon — allowing them to see what has been taken and what is left. Small interparenchymal lesions would be much easier to remove definitively if live imaging were available interoperatively.”

Ms. Svetlana, Director, Time Medical International Ventures (I) P Ltd: “With Dr Cherian’s expertise and vision, Time Medical is entering an exciting new phase of innovation. The Interop MRI represents our commitment to developing cutting-edge, accessible solutions that bring world-class imaging into the surgical environment.”

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Agartala (Tripura) [India], November 4: In a region celebrated for tea gardens and handicrafts rather than technological ambition, a quiet revolution is unfolding. Codonmind Nexus Private Limited, the Northeast’s pioneering neurotechnology startup, is developing brain-computer interface devices and advanced neurological research tools positioned to compete with national players in a market projected to reach USD 164 million in India by 2030.

Leading this venture is Dr. Saikat Kar, a 31-year-old neuroscientist whose trajectory defies conventional expectations. From a ₹2,000 rented room in Agartala to prestigious research positions at Harvard Medical School and the University of Edinburgh, Kar has returned home with an audacious conviction: cutting-edge neuroscience and entrepreneurship can thrive in India’s peripheral regions.

Unlike typical Indian startups clustered in Bangalore, Pune, and Gurgaon, Codonmind Nexus operates from Agartala, developing prototypes for both clinical healthcare and consumer wellness markets. The company’s dual-focus strategy acknowledges a critical reality. Timing proves strategic. Tripura has recorded 66% growth in startup recognitions over five years—the highest among Northeastern states. The state’s Tripura Startup Policy 2024, launched in January 2025, provides incubation support, operational funding, and access to national schemes nurturing entrepreneurs. “Tripura stands at an important inflection point,” noted Jeya Ragul Geshan B, IFS, Director of IT for the Government of Tripura, at the Tamil Nadu Global Startup Summit 2025.

Dr. Kar’s journey—known to thousands of students as “Dr. SK Sir”—challenges the narrative of necessity-driven migration. Son of a lower-division clerk earning below ₹12,000 monthly, he attended Khowai Government English Medium School initially where he confronted inadequate teaching resources. Despite these constraints, he became Tripura’s AIPMT state topper in 2012 from Shishu Bihar Higher Secondary School. Limited knowledge about central counseling and financial constraints led him to AGMC rather than premiere medical institutions. What could have concluded as a story of missed chances became one of deliberate self-education and intellectual ambition.

His acceptance to Harvard Medical School’s Global Clinical Research Scholar Program and a Neuroscience Research Masters at the University of Edinburgh in 2022 marked him as the first in his extended family to pursue STEM education abroad. At Edinburgh, he joined The Physiological Society, Royal Society of Biology, and Federation of European Neuroscience Societies (FENS), completed five research projects, published in top-tier scientific journals, and filed UK patents—all while maintaining full-time coursework.

In 2023, with secured job offers from UK institutions, Kar made a surprising choice: he would return to Agartala. Rather than leveraging international credentials for comfortable careers in Boston or Edinburgh, he rebuilt his educational institute, assembled a team of scientists and engineers, and began developing neurotech prototypes while publishing high-quality research. His platform, Dr. SK’s Biology, transcends conventional entrance exam preparation. It serves as a proving ground for translating complex neuroscience concepts into accessible frameworks—a skill directly transferable to designing user-centered neurotechnology products.

While India accounts for only 2.5% of the global brain-computer interface market, domestic demand surges due to increasing mental health awareness, and growing wearable adoption. Codonmind Nexus directly addresses this critical gap with research-backed solutions. Deep-tech ventures face familiar obstacles: prohibitive development costs, complex regulatory pathways, and sustained funding challenges. Yet Tripura’s evolving ecosystem offers distinctive advantages. State government startup incentives, expanding AGMC medical infrastructure, and strengthening national research network connectivity provide crucial institutional backing.

In an era when “brain drain” dominates narratives about talent migration from smaller Indian states, Codonmind Nexus exemplifies “brain circulation”—where knowledge flows homeward to create opportunities otherwise nonexistent. “I’ve taken many risks in my life,” reflects Kar. “Maybe I will succeed, maybe not, but I will keep taking these risks, never settling anywhere when things look solid.” If successful, this Northeast startup could catalyze a transformative model: how advanced scientific entrepreneurship flourishes beyond traditional innovation hubs, positioning Tripura as an emerging deep-tech ecosystem. The revolution unfolding in Agartala may ultimately reshape India’s biotech landscape.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Mumbai (Maharashtra) [India], November 4: Harsheep Hortico Limited (BSE: HARSHDEEP), specializing in the manufacture and export of pots, planters, garden accessories, and outdoor furniture; announced its Unaudited financials for H1 FY26.

Key H1 FY25 Financial Highlights

Key Financial Highlights (Consolidated) – H1 FY2025-26

• Revenue for H1 FY2025–26 was ₹37.84 crore, compared to ₹24.09 crore in H1 FY2024–25, reflecting a year-over-year growth of 57.1%.
• Profit Before Tax (PBT) for H1 FY2025–26 stood at ₹8.88 crore, up from ₹6.10 crore in H1 FY2024–25, marking a year-over-year increase of 34.95%.
• Profit After Tax (PAT) for H1 FY2025–26 was ₹5.70 crore versus ₹4.22 crore in H1 FY2024–25, indicating a year-over-year growth of 34.94%.

Harshdeep Hortico Limited demonstrated strong performance in H1 FY26, reflecting the company’s resilience, operational excellence, and strategic focus within the horticulture and outdoor lifestyle sector. Commenting on the results, Mr. Harshit Shah, Director, stated that the company’s growth in net profit and prestigious contracts—such as those with Mumbai and Mangalore airports—underscore Harshdeep’s market strength. To support its long-term growth ambitions, the company expanded its manufacturing capabilities with the installation of new rotational and injection moulding machines, increasing total production capacity to 1,440 tonnes per year. This strategic investment is expected to enhance productivity, product quality, and operational efficiency while reinforcing the company’s commitment to sustainability and innovation.

Harshdeep also continued to strengthen its retail and distribution footprint with a new flagship store in Ahmedabad and dealer showrooms across Patna, Kolhapur, Hisar, NCR Delhi, Kochi, and Jaipur. The company’s Agri shield division, launched last year, has emerged as a key growth driver with its premium range of Agro shade nets. In response to growing demand, Harshdeep invested in advanced automated machinery, adding 200 tons of annual production capacity dedicated to Agri shield. With over 500 unique designs and 2,200 SKUs, Harshdeep Hortico remains focused on delivering sustainable, high-quality products that blend design excellence with durability, positioning the company for continued growth and value creation.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Manama, [Bahrain], November 4: The Asian Travel Expo 2025 proudly announces Gulf Air Holidays as a Co-Sponsor for the much-awaited international travel and tourism showcase taking place on 8th, 9th, and 10th December 2025 at Exhibition World Bahrain.

This collaboration marks a significant step in uniting leading players in the global travel and tourism industry, reinforcing Bahrain’s growing reputation as a world-class destination for business, leisure, and cultural tourism.

Gulf Air Holidays, the leisure arm of Bahrain’s national carrier Gulf Air, has earned a stellar reputation for creating unique, customized travel experiences across the globe. By partnering with the Asian Travel Expo 2025, the brand aims to further enhance its regional and international presence while supporting Bahrain’s vision of becoming a central hub for travel and tourism innovation.

Speaking about the collaboration, Abdul Musaddiq, Managing Director of the Asian Arab Trade Chamber of Commerce, said:

“Gulf Air Holidays joining us as Co-Sponsor is a testament to the growing recognition of the Asian Travel Expo as a global platform for travel innovation and partnership. Their participation reinforces our mission to create opportunities for cross-border tourism, investment, and cultural exchange. We look forward to a successful and impactful association that benefits all stakeholders.”

The Asian Travel Expo 2025 is set to welcome participants from over 25 countries, including tourism boards, destination management companies, airlines, hotel chains, and industry professionals. The event promises to be a hub of networking, business exchange, and destination showcasing — bridging continents through travel and trade.

Trade visitors and buyers are encouraged to visit Gulf Air Holidays at Booth No. C2 to explore exclusive offers, holiday experiences, and strategic partnership opportunities throughout the Expo.

The Asian Travel Expo 2025 and the prestigious Asian Travel Awards 2025 are organized by the Asian Arab Trade Chamber of Commerce and managed by Show Buddy Global W.L.L. These landmark events aim to celebrate excellence, innovation, and collaboration in the global travel and tourism industry.

For more details, visit https://asiantravelexpo.com/

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Mumbai (Maharashtra) [India], November 4: Infomerics Valuation and Ratings Pvt. Ltd. has revised the outlook of Globe Civil Projects Limited’s long-term bank facilities from Stable to Positive while reaffirming the rating at IVR BBB. The short-term rating of IVR A3+ has also been reaffirmed

The revision reflects the company’s strengthened capital structure post its ₹119 crore IPO, improved profitability, and a robust order book of ₹1,001 crore, providing healthy revenue visibility.

• FY25 Revenue: ₹325.99 crore (+11% YoY)
• EBITDA Margin: 16.43% (vs 15.10% in FY24)
• PAT: ₹24.05 crore (+57% YoY)

For more details: https://nsearchives.nseindia.com/corporate/GLOBE2024_30102025140140_INTIMATION.pdf

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.